cro.directory
← Compare landing

Axcelead Drug Discovery Partners, Inc. vs Oncodesign Services

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/axcelead/oncodesign-services

CategoryAxcelead Drug Discovery Partners, Inc.Oncodesign Services
Listed sitecrocro
SummaryAxcelead provides integrated drug discovery research services across small molecules, nucleic acids, antibodies, and peptides, with specialized expertise in oncology, immunology, and neurology. Founded in 2017 from Takeda's research base, the company serves pharmaceutical companies, bioventures, and academia with above-industry screening hit rates and project success metrics.Contract research organization specializing in drug discovery and preclinical services for oncology, inflammation, and infectious diseases since 1995.
Services
  • Discovery Research
  • Target Identification & Validation
  • High-Throughput Screening
  • Medicinal Chemistry
  • Computational & In-Silico Drug Discovery
  • In Vitro Pharmacology
  • In Vitro ADME / DMPK
  • Safety Pharmacology
  • Genetic Toxicology
  • In Vivo PK / PD Studies
  • In Vivo Efficacy Models
  • Preclinical In Vivo Studies
  • Preclinical In Vitro Studies
  • Specialized & Large-Animal Models
  • GLP Toxicology
  • Biomarker Assays
  • Flow Cytometry Services
  • Bioanalysis
  • Bioinformatics & Data Science
  • Genomics & Sequencing Services
  • Proteomics Services
  • Pathology & Histology Services
  • Translational Research
  • Oncology Specialty Services
  • Immunology & Inflammation Services
  • CNS Specialty Services
  • Cardiovascular & Metabolic Specialty Services
  • Discovery Research
  • Target Identification & Validation
  • Medicinal Chemistry
  • In Vitro Pharmacology
  • In Vitro ADME / DMPK
  • In Vivo PK / PD Studies
  • In Vivo Efficacy Models
  • Preclinical In Vivo Studies
  • Specialized & Large-Animal Models
  • Bioanalysis
  • Immunogenicity Assays (ADA / NAb)
  • Biomarker Assays
  • Clinical Imaging Core Lab
  • Oncology Specialty Services
  • Immunology & Inflammation Services
  • Virology Services
  • GLP Toxicology
  • Safety Pharmacology
  • Translational Research
  • Preclinical In Vitro Studies
  • Regulatory Affairs
  • LC-MS Bioanalysis (Small Molecule)
  • High-Throughput Screening
  • Genetic Toxicology
  • Computational & In-Silico Drug Discovery
  • Carcinogenicity Studies
  • DART (Reproductive & Developmental Toxicology)
  • Flow Cytometry Services
  • Analytical Method Development & Validation
  • ICH Stability Studies
  • Ligand-Binding Bioanalysis (Large Molecule)
Modalities
  • Small Molecule
  • Oligonucleotide
  • Antibody-Drug Conjugate (ADC)
  • Biologics (Monoclonal Antibodies)
  • Peptide
  • mRNA
  • Small Molecule
  • Biologics (Other)
  • Antibody-Drug Conjugate (ADC)
  • Radiopharmaceutical
Indications
  • Oncology
  • Immunology
  • Neurology
  • Nephrology
  • Metabolic
  • Cardiovascular
  • Oncology
  • Immunology
  • Infectious Disease
  • Dermatology
  • Gastroenterology
  • Nephrology
  • Metabolic
  • Rare Disease
  • Respiratory
LocationsData not yet provided.
  • Headquarters, Dijon, Bourgogne-Franche-Comté, France
  • Headquarters
CertificationsData not yet provided.Data not yet provided.
ReviewsReview summary appears after site-level review signal gate opens.Review summary appears after site-level review signal gate opens.